367 related articles for article (PubMed ID: 25449861)
1. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability.
Dobson ET; Strawn JR
Paediatr Drugs; 2016 Feb; 18(1):45-53. PubMed ID: 26660158
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
Mills JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
Luft MJ; Lamy M; DelBello MP; McNamara RK; Strawn JR
Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):50-62. PubMed ID: 29358037
[TBL] [Abstract][Full Text] [Related]
7. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
8. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
9. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
10. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
[TBL] [Abstract][Full Text] [Related]
12. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
[TBL] [Abstract][Full Text] [Related]
15. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
18. Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.
Strawn JR; Dobson ET; Giles LL
Curr Probl Pediatr Adolesc Health Care; 2017 Jan; 47(1):3-14. PubMed ID: 28043839
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
Seidel L; Walkup JT
J Child Adolesc Psychopharmacol; 2006; 16(1-2):171-9. PubMed ID: 16553537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]